 complex femoropopliteal artery lesions: the
randomized VIASTAR trial (Viabahn endoprosthesis with PROPATEN bioactive surface [VIA] versus bare nitinol stent in the treatment of long lesions in superÔ¨Åcial femoral artery occlusive disease).
J Am Coll Cardiol 2013;62:1320-7.
214. Johnston PC, Vartanian SM, Runge SJ, Hiramoto JS